FULC
Fulcrum Therapeutics Inc
Price:  
3.96 
USD
Volume:  
478,274.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FULC WACC - Weighted Average Cost of Capital

The WACC of Fulcrum Therapeutics Inc (FULC) is 5.6%.

The Cost of Equity of Fulcrum Therapeutics Inc (FULC) is 7.50%.
The Cost of Debt of Fulcrum Therapeutics Inc (FULC) is 5.00%.

Range Selected
Cost of equity 5.50% - 9.50% 7.50%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.6% - 6.6% 5.6%
WACC

FULC WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.36 0.83
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.50% 9.50%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 4.6% 6.6%
Selected WACC 5.6%